Browse

Sonothera's ultrasound gene therapy delivery, a new Alzheimer's drug controversy, and more biotech news from The Readout

Last summer, zero biotechs made it onto the public markets as the industry weathered a seven-month dry spell for initial share sales. This time around, it's a summer IPO party as six

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.